Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow RAPID MICRO BIOSYSTEMS, INC.

Get SEC filing alerts via email and in your feed for RAPID MICRO BIOSYSTEMS, INC.

RPID

RAPID MICRO BIOSYSTEMS, INC.

About RAPID MICRO BIOSYSTEMS, INC.

Rapid Micro Biosystems specializes in automating microbial quality control testing for pharmaceutical manufacturing. Its flagship Growth Direct platform offers rapid, accurate, and secure detection of microbial contamination, supporting biologics, vaccines, and sterile injectables. The company's solutions enhance operational efficiency, data integrity, and regulatory compliance, serving global pharmaceutical and biotech companies. Its business model emphasizes recurring revenue from system sales, consumables, and support services.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from RAPID MICRO BIOSYSTEMS, INC.

1
1
RAPID MICRO BIOSYSTEMS, INC. Rapid Micro Biosystems Reports 11.1% Revenue Growth but Increased Net Loss in Q1 2026

Via official filing (AI summary) | 20 days ago | 0 comments

2
1
RAPID MICRO BIOSYSTEMS, INC. Rapid Micro Biosystems Reports $33.6M Revenue and $47.1M Net Loss for Fiscal Year 2025

Via official filing (AI summary) | 3 months ago | 0 comments

3
1
RAPID MICRO BIOSYSTEMS, INC. Rapid Micro Biosystems Reports Q3 2025 Revenue Growth Despite Net Loss

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
RAPID MICRO BIOSYSTEMS, INC. Rapid Micro Biosystems Reports 9.7% Revenue Growth in Q2 2025, Net Loss Improves

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
RAPID MICRO BIOSYSTEMS, INC. Rapid Micro Biosystems Reports $7.2 Million Revenue in Q1 2025, 28.4% Increase Year-Over-Year

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
RAPID MICRO BIOSYSTEMS, INC. Rapid Micro Biosystems Reports $28.1 Million Revenue for Fiscal Year 2024, Net Loss Improves

Via official filing (AI summary) | over 1 year ago | 0 comments

7
1
RAPID MICRO BIOSYSTEMS, INC. Rapid Micro Biosystems Reports 23.7% Revenue Growth, Improved Losses in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments